S D Webley

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

Roslyn J. Francis, Sanjay Sharma, Caroline J. Springer et al. · British Journal of Cancer · 2002 · 162 citations · Full text

Pharmacy, Oncology, Pharmacology +15

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition

S D Webley, Sarah J. Welsh, Ann L. Jackman et al. · British Journal of Cancer · 2001 · 54 citations · Full text

Life Sciences, Cell Biology, Oncology +9

Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331

S D Webley, Anthea Hardcastle, Robert D. Ladner et al. · British Journal of Cancer · 2000 · 46 citations · Full text

Medicine, Oncology, Pharmacology +12

Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material

S D Webley, Roslyn J. Francis, RB Pedley et al. · British Journal of Cancer · 2001 · 37 citations · Full text

Medicine, Oncology, Pharmacology +14